The Influence of Cost-Effectiveness and Other Factors on Nice Decisions

Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project

(2014) R Baker et al.   HEALTH TECHNOLOGY ASSESSMENT

An Investigation Into The Key Drivers Influencing The Decision Making Of The Scottish Medicines Consortium

(2013) I. Mshelia et al.   VALUE IN HEALTH

Reimbursement Decisions of the All Wales Medicines Strategy Group

(2012) Warren G. Linley et al.   PHARMACOECONOMICS

An Analysis of NICEʼs ‘Restricted’ (or ‘Optimized’) Decisions

(2010) Phill OʼNeill et al.   PHARMACOECONOMICS

Multiple imputation using chained equations: Issues and guidance for practice

(2010) Ian R. White et al.   STATISTICS IN MEDICINE

Pharmacoeconomics: NICE's approach to decision-making

(2009) Michael Rawlins et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Public funding of new cancer drugs: Is NICE getting nastier?

(2009) Anne R. Mason et al.   EUROPEAN JOURNAL OF CANCER

The Role of Value for Money in Public Insurance Coverage Decisions for Drugs in Australia: A Retrospective Analysis 1994-2004

(2008) Anthony H. Harris et al.   MEDICAL DECISION MAKING

The NICE Cost-Effectiveness Threshold

(2008) Christopher McCabe et al.   PHARMACOECONOMICS